Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Faces of Keen Sword 27 - Head of German DMBV
DVIDS - Georgia
In Japan, Exercise Keen Sword 27 is underway between the U.S. military, Japanese Self-Defense Forces, and members from Australia, Canada, France, Germany, the Netherlands, New Zealand and the Philippines.
Recursion to Host Webinar Focused on Updated REC-4881 (FAP) Data from CGA-IGC on Tuesday, November 3
GlobeNewswire, Inc.
Webinar will include earnings updates and REC-4881 data as well as KOL and patient panels, presented live from CGA-IGC on Tuesday, November 3, 2026 at 8:00 am ET / 6:00 am MT / 1:00 pm GMT Third quarter 2026 results will be released prior to the...
Arbutus Announces Final Results of Its US$230 Million Modified “Dutch Auction” Tender Offer
GlobeNewswire, Inc.
WARMINSTER, Pa., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on infectious disease, today announced the final results of its tender...
Medical Devices Market Size to Hit $817.78 Billion by 2031 – MarketsandMarkets™
GlobeNewswire, Inc.
Delray Beach, FL, Sept. 18, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ projects the global medical devices market size will grow from USD 580.79 billion in 2026 to USD 817.78 billion by 2031, at a CAGR of 7.1% during the forecast period.
ASML reports transactions under its current share buyback program
GlobeNewswire, Inc.
ASML reports transactions under its current share buyback program VELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share buyback program.
Arbutus Announces Preliminary Results of Its US$230 Million Modified “Dutch Auction” Tender Offer
GlobeNewswire, Inc.
WARMINSTER, Pa., Sept. 30, 2026 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on infectious disease, today announced the preliminary results of its...
uniQure Announces Additional Data from Ongoing Phase I/II Studies of ifezuntirgene inilparvovec (AMT-130) in Huntington’s Disease Showing Continued Slowing of Disease Progression
GlobeNewswire, Inc.
~ In 12 high-dose patients at 48 months, both cUHDRS and TFC continued to demonstrate meaningful slowing of disease progression and clear dose-dependent response; the primary endpoint of cUHDRS showed 44% slowing of disease progression...
NewAmsterdam Pharma Doses First Participant in Phase 2b SPINOZA Trial Evaluating Obicetrapib in Preclinical Alzheimer’s Disease
GlobeNewswire, Inc.
- SPINOZA is studying obicetrapib in adults with biomarker evidence suggestive of preclinical Alzheimer’s disease who do not have noticeable memory or functional symptoms- - The study will evaluate changes in blood-based biomarkers associated with...
The World’s Most Important Health Data Can’t Use Frontier AI. Until Now: Lifebit Launches AI Scientist Studio
EIN Presswire
Model-agnostic platform lets researchers build and deploy custom AI scientist agents within Federated Trusted Research Environments.
AIM ImmunoTech Highlights Ampligen’s Potential Role in the Evolving Pancreatic Cancer Treatment Landscape Following FDA Approval of Revolution Medicines’ Daraxonrasib
GlobeNewswire, Inc.
Company CEO outlines the differentiated mechanism and clinical potential of Ampligen in pancreatic cancer Survival data highlighted in accompanying chart show Ampligen-associated median overall survival of 34.8 months in a selected pancreatic...
Still standing together: U.S.-Dutch partnership carries Market Garden legacy forward
DVIDS - Georgia
NIJMEGEN, Netherlands — “In 1776, you stood with us. In 1944, we stood with you. And in 2026, we still stand together.” U.S. Army Maj. Nicholas M. Chopp delivered those words during the John R. Towle commemoration in Oosterhout, Netherlands, on...
Katz Amsterdam Charitable Trust Announces 2026 Youth Winter Sports Grants
EIN Presswire
$1.1 million in 2026 grants to reach an estimated 2,521 youth, part of the Trust's $10 million, multi-year commitment to expanding youth access to winter sports BOULDER, CO, UNITED STATES, September 23, 2026 /EINPresswire.com/ -- The Katz...
MEGlobal becomes first U.S. ethylene glycol producer to earn ISCC Carbon Footprint Certification
EIN Presswire
Certification advances EQUATE Group’s ESG objectives and supports customers OYSTER CREEK, TX, UNITED STATES, October 27, 2026 /EINPresswire.com/ -- OYSTER CREEK, Texas, October 27, 2026 – MEGlobal Americas Inc., an EQUATE Group company, has...
NewAmsterdam Pharma and Menarini Group Receive European Commission Approval for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
GlobeNewswire, Inc.
- First-in-Class approval supported by Phase 3 BROADWAY, BROOKLYN, and TANDEM trials demonstrating significant LDL-C reductions with favorable tolerability profile- - First global regulatory approval of obicetrapib marks a defining milestone for...
Top 10 Non-dairy Creamer for Coffee Manufacturers in 2026: Advancing Premium Beverage Solutions
EIN Presswire
A 2026 guide to ten non-dairy creamer manufacturers for coffee applications.
From liberation to legacy: Gavin helped build a lasting U.S.-Dutch bond in Nijmegen
DVIDS - Georgia
NIJMEGEN, Netherlands — U.S. Army Maj. Gen. James M. Gavin arrived near Nijmegen in September 1944 commanding the 82nd Airborne Division during Operation Market Garden.
Kiteworks Achieves NEN 7510-1:2024 Certification for Healthcare Data Security in the Netherlands
EIN Presswire
Certificate NL 3069.1.1 covers the Kiteworks Control Plane and Zivver Secure Communications Services.
Matisse Pharmaceuticals closed Series A financing round to advance isupartob sodium through phase 2 clinical development
GlobeNewswire, Inc.
Geleen, September 17, 2026 Matisse Pharmaceuticals B.V., a clinical stage company developing isupartob sodium for the treatment of sepsis, today announced the successful completion of its Series A financing round.
Philips-led projects win ITEA awards for advancing AI-enabled healthcare innovation
GlobeNewswire, Inc.
September 16, 2026 SYMPHONY receives ITEA’s highest excellence award for connected healthcare ecosystems AI FORSchung is recognized for innovation in AI-powered fiber-optic sensing Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA),...
Global Value-Based Healthcare Market is Predicted to Cross USD 60 Billion by 2034 | DelveInsight
GlobeNewswire, Inc.
New York, USA, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Global Value-Based Healthcare Market is Predicted to Cross USD 60 Billion by 2034 | DelveInsight The value-based healthcare market is witnessing robust growth as healthcare systems worldwide shift...
Sign up for:
Healthcare News Netherlands
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.